Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil/propofol versus sufentanil/propofol for analgosedation in mechanically ventilated intensive care patients
2006-001276-20Phase 3Terminated
- Sponsor
- GSK
- Start
- Oct 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial comparing Remifentanil + propofol with Sufentanil + propofol (2 arms). Primary endpoint: Time from initiation of analgosedation using the study substance to extubation. Started Oct 2006; status: terminated.
02
Drugs
remifentanilsufentanilpropofol
Beyond the preview
Go deeper on 2006-001276-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001276-20.